Shares of Biotest Aktiengesellschaft (ETR:BIO – Get Free Report) were down 0.5% during mid-day trading on Wednesday . The stock traded as low as €41.00 ($43.62) and last traded at €41.40 ($44.04). Approximately 1,000 shares traded hands during trading, a decline of 48% from the average daily volume of 1,927 shares. The stock had previously closed at €41.60 ($44.26).
Biotest Aktiengesellschaft Stock Performance
The firm has a 50 day simple moving average of €41.69 and a 200-day simple moving average of €41.65. The company has a debt-to-equity ratio of 116.50, a current ratio of 2.45 and a quick ratio of 1.66. The company has a market cap of $823.26 million, a price-to-earnings ratio of 10.02 and a beta of 0.24.
Biotest Aktiengesellschaft Company Profile
Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the therapeutic areas of clinical immunology, haematology, and intensive care medicine.
Further Reading
- Five stocks we like better than Biotest Aktiengesellschaft
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Top-Performing Non-Leveraged ETFs This Year
- What Are the FAANG Stocks and Are They Good Investments?
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- 3 Warren Buffett Stocks to Buy Now
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
Receive News & Ratings for Biotest Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotest Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
